HCA Healthcare Q3 Earnings Beat Estimates on Higher Admissions - Zacks Investment Research
HCA Healthcare Q3 Earnings Beat Estimates on Higher Admissions - Zacks Investment Research（摘要待生成）
Will HCA Healthcare's Q3 Earnings Benefit From Higher Admissions? - Zacks Investment Research
Will HCA Healthcare's Q3 Earnings Benefit From Higher Admissions? - Zacks Investment Research（摘要待生成）
HCA Healthcare Raises FY2026 GAAP EPS Guidance from $28.70-$30.50 to $29.60-$30.50 vs $29.46 Est; Raises FY2026 Sales Guidance from $77.000B-$79.500B to $78.250B-$79.500B vs $78.517B Est
HCA Healthcare Raises FY2026 GAAP EPS Guidance from $28.70-$30.50 to $29.60-$30.50 vs $29.46 Est; Raises FY2026 Sales Guidance from $77.000B-$79.500B to $78.250B-$79.500B vs $78.517B Est（摘要待生成）
HCA Healthcare, Inc. Reports Q3 2026 Financial Results
HCA Healthcare, Inc. reported third-quarter 2026 revenue of $19.85 billion and adjusted earnings per share of $7.22, both exceeding analyst expectations.
HCA Healthcare Q3 2026 Earnings Call Transcript
HCA Healthcare (NYSE:HCA) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs.
HCA Healthcare Beats Wall Street Estimates, But $400 Million Coverage Gap Trips the Stock
HCA Healthcare beat Q3 2026 estimates and raised guidance, but shares slid following a $400 million pretax hit from rising uninsured patient volumes.
Reuters: HCA’s broadly flat 2027 earnings outlook pressures hospital shares
On Oct. 27, CEO Sam Hazen said HCA expects 2027 earnings to be generally consistent with 2026; a full outlook is due in January. HCA expects 2%–3% volume growth, but cited uninsured-patient increases, exchange contraction and lower Medicaid payments. Shares fell more than 5%; Tenet fell 2% and UHS 6%. HCA said Q3 uninsured-patient mix cut pretax income about $400M.
HCA shares fell 3.29% on Q3 results despite beating estimates
Event date: 2026-10-27. HCA closed at $449.96, down $15.30 (3.29%) from $465.26. Q3 adjusted EPS was $7.22 versus estimates of $6.63-$6.74; revenue was $19.849B versus $19.33B estimates. Net income fell 3.9% to $1.579B. HCA said FY26 results should be in the upper half of prior guidance ranges.
HCA Healthcare, 8-K (2.02, 7.01, 8.01, 9.01): reported results of operations
HCA Healthcare reported third-quarter 2026 revenue of $19.849 billion, net income of $1.579 billion and adjusted EBITDA of $3.918 billion, and said full-year operating results are expected in the upper half of previously issued guidance ranges.
HCA Healthcare Q3 Adj. EPS $7.22 Beats $6.66 Estimate, Sales $19.849B Beat $19.332B Estimate
HCA Healthcare Q3 Adj. EPS $7.22 Beats $6.66 Estimate, Sales $19.849B Beat $19.332B Estimate（摘要待生成）
HCA Healthcare Declares Quarterly Cash Dividend
HCA Healthcare announced a quarterly cash dividend payable on December 29, 2026.
Sarah Cannon Research Institute at HCA Healthcare to Present Clinical Trial Data
The Sarah Cannon Research Institute (SCRI) at HCA Healthcare announced upcoming presentations of clinical trial results for oncology treatments at an industry event.